Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Bristol-Myers extends lead with new Opdivo indication
BioPharma Dive
Tue, 05/17/16 - 05:20 pm
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Yahoo
Mon, 04/25/16 - 08:02 am
Bristol-Myers Squibb
Opdivo
metastatic head and neck squamous cell carcinoma
Bristol-Myers's Opdivo Extends Survival in Head, Neck Cancer
Bloomberg
Tue, 04/19/16 - 06:14 pm
Bristol-Myers Squibb
Opdivo
head and neck cancer
Bristol Myers Set to Enhance Dominance in Immunotherapies Market
Bidness, ETC
Sat, 04/16/16 - 04:10 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Hodgkin's lymphoma
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Supplemental Biologics License Application for Opdivo® (nivolumab) for the Treatment of Classical Hodgkin Lymphoma Patients
Yahoo
Thu, 04/14/16 - 09:13 am
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Bristol-Myers Squibb Is Crushing Its Competition In The Cancer Treatment Market
Seeking Alpha
Mon, 04/4/16 - 07:57 am
Bristol-Myers Squibb
cancer
oncology
Merck
Opdivo
Cholesterol pill boosts cancer immunotherapy, at least in mice
Yahoo/Reuters
Thu, 03/17/16 - 05:03 pm
Opdivo
Keytruda
Avasimibe
Merck
Bristol-Myers Squibb
cancer immunotherapy
Pfizer
Why This Bristol-Myers Cancer Drug Is Crushing Its Rivals
Fortune
Wed, 03/16/16 - 10:16 am
Bristol-Myers Squibb
Opdivo
Merck's Keytruda held back by docs who don't want to wait for diagnostics
Fierce Pharma Marketing
Mon, 03/14/16 - 05:59 pm
Merck
Keytruda
physicians
Opdivo
Bristol-Myers Squibb
Bristol-Myers Squibb’s Opdivo: Why Is It Important?
Yahoo/Market Realist
Thu, 03/10/16 - 09:32 pm
Bristol-Myers Squibb
Opdivo
This $150,000 Cancer Treatment Saved a Pharma Company
Bloomberg
Fri, 03/4/16 - 02:12 pm
Ono Pharmaceutical
Opdivo
Bristol-Myers Squibb
Japan
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Opdivo
immuno-oncology
Bristol-Myers Squibb
Eli Lilly
Merck
Roche
AstraZeneca
Novartis
Rivals chase Bristol-Myers in cancer immunotherapy drug race
Yahoo/Reuters
Fri, 02/26/16 - 11:09 am
Bristol-Myers Squibb
cancer immunotherapy
Roche
AstraZeneca
Merck
Opdivo
Bristol-Myers shares could rise 25 pct on cancer drug-Barron's
Yahoo/Reuters
Tue, 02/16/16 - 10:00 am
Bristol-Myers Squibb
Opdivo
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Motley Fool
Mon, 02/8/16 - 10:23 am
Big Pharma
JNJ
Novartis
Bristol-Myers Squibb
Darzalex
Entresto
Opdivo
BMS' Opdivo evens the score in melanoma with two new FDA green lights
Fierce Pharma
Mon, 01/25/16 - 10:32 pm
Bristol-Myers Squibb
Opdivo
FDA
melanoma
Bristol-Myers' Opdivo Gets Nod for Melanoma From U.K. Regulator
Bloomberg
Thu, 01/21/16 - 07:52 pm
Bristol-Myers Squibb
Opdivo
melanoma
UK
NICE
Cancer Drugs: Strong Growth for Bristol’s Opdivo, Pfizer’s Ibrance
Barron's
Wed, 12/30/15 - 09:01 pm
Bristol-Myers Squibb
Opdivo
Pfizer
Ibrance
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
next ›
last »